Letrobol 2.5 (Letrozole USP 2.5mg) is an oral aromatase inhibitor. It works by significantly decreasing estrogen production in the body. Primarily prescribed as a breast cancer treatment, it is also utilized off-label to stimulate ovulation.
Ledifos 90/400 (Ledipasvir 90 mg + Sofosbuvir 400 mg) is a combination antiviral medication manufactured by Hetero Healthcare Ltd. It is used to treat chronic Hepatitis C virus (HCV) infection.
| Strength | 90 +400 |
| Primary Indication | Chronic Hepatitis C (HCV) Treatment |
| Drug class | Direct-Acting Antiviral (DAA) |
| Dosage Form | Oral Tablets |